95826-4

SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection

Active

Term Description

This panel contains results for the detection of Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), initially known as 2019-Novel Coronavirus (2019-nCoV), in a saliva specimen using nucleic acid amplification assays with probe-based detection for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC

Part Descriptions

LP417539-6 SARS coronavirus 2 RNA panel
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC: coronavirus/2019-ncov][https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance] Source: Regenstrief LOINC

LP7565-7 Saliva
Saliva is produced primarily by the parotid, submaxillary, and sublingual glands. It is secreted at the rate of 0-3 milliliters per minute which is affected by various factors including anxiety, hydration and hunger. Oral fluid is broadly used to test for drugs of abuse in employment and forensic settings, and is especially useful since it is difficult to adulterate, is quick and is non-invasive. Oral fluid is used to test a variety of analytes, including to test alcohol, HIV and other antibodies, therapeutic drugs and steroids, but its primary use is to test for drugs of abuse including amphetamines, cocaine and metabolites, opioids, methadone, cannabis and heroin. PMID: 17268583 Source: Regenstrief LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC	Name	R/O/C	Cardinality	Example UCUM Units
95826-4	SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection
Indent95425-5	SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent96448-6	SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
Indent96958-4	SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2
Indent95824-9	SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent96091-4	SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent96765-3	SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent94845-5	SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent95823-1	SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection

Fully-Specified Name

Component: SARS coronavirus 2 RNA panel
Property: -
Time: Pt
System: Saliva
Scale: -
Method: Probe.amp.tar

Additional Names

Short Name: SARS-CoV-2 RNA Pnl Sal NAA+probe
Display Name: SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Sal)
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) RNA Panel, Saliva

Basic Attributes

Class: PANEL.MICRO
Type: Laboratory
First Released: Version 2.69
Last Updated: Version 2.70
Order vs. Observation: Order
Panel Type: Panel

Member of these Groups Get Info

LOINC Group	Group Name
LG51017-8	SARSCoV2 detection
LG51019-4	SARSCoV2 molecular detection

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	SARS-Coronavirus 2 RNA (Liste):-:Zeitpunkt:Speichel:-:Zielfragmentamplifikation mit Sondendetektion
es-ES	Spanish (Spain)	Panel de ARN del SARS-CoV-2 (COVID-19):Propiedades mixtas (sólo paneles):Punto temporal:Saliva:-:Sonda con amplificación dirigida
es-MX	Spanish (Mexico)	Panel de ARN del coronavirus 2 del SARS:-:Punto temporal:Saliva:-:Amplificación de ácidos nucleicos con detección de sonda
fr-FR	French (France)	Coronavirus SARS-CoV-2 ARN panel:-:Ponctuel:Salive:-:PCR amplification de cible
fr-CA	French (Canada)	Coronavirus 2 du SRAS, ARN:-:Temps ponctuel:Salivaire:-:Sonde avec amplification de la cible
it-IT	Italian (Italy)	SARS coronavirus 2, panel RNA:-:Pt:Saliva:-:Sonda.amp.tar Synonyms: Coronavirus della SARS Microbiologia Panel RNA di SARS-CoV-2 (COVID-19) Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Set di prescrizione microbiologia Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA
nl-NL	Dutch (Netherlands)	SARS-CoV-2 RNA panel:-:moment:speeksel:-:probe-detectie Synonyms: probe.amp.tar SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
zh-CN	Chinese (China)	SARS 冠状病毒 2 RNA 组套:-:时间点:唾液:-:探针法.基因扩增.靶向 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ II SARS 冠状病毒 2 RNA 组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒借助扩增的探针方法;借助扩增的探针法;探针法.扩增借助靶向扩增的探针方法;借助靶向扩增的探针法;探针法.扩增.靶向医嘱套餐医嘱套餐类医嘱套餐组医嘱组医嘱组.微生物学;实验室组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）类.微生物学试验;医嘱组.微生物学试验;医嘱组类.微生物学;医嘱组类.微生物学试验;实验室医嘱组类.微生物学;微生物学医嘱组;微生物学医嘱组类医嘱组合医嘱组合类医嘱组套医嘱组套类医嘱组类多重;多重型;多重标尺类型;多重精度类型套餐套餐医嘱套餐医嘱组套餐医嘱组类实验室医嘱套餐实验室医嘱套餐类实验室医嘱组实验室医嘱组合类实验室医嘱组套实验室医嘱组套类实验室套餐医嘱组实验室套餐医嘱组类实验室检验项目医嘱组合类实验室检验项目组合类微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）扩增型扩增性时刻;随机;随意;瞬间核糖核酸;Ribonucleic acid 检验医嘱组合类检验项目医嘱组合类检验项目组合类津;津液;涎组组合组合医嘱组合类组套经过扩增的脱氧核糖核酸探针

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95826-4
Questionnaire definition: https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/95826-4

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.